| 000 | 01148 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514011521.0 | ||
| 264 | 0 | _c20011204 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a1472-4472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aElices, M J | |
| 245 | 0 | 0 |
_aTresperimus (Laboratoires Fournier). _h[electronic resource] |
| 260 |
_bCurrent opinion in investigational drugs (London, England : 2000) _cMar 2001 |
||
| 300 |
_a372-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarbamates _xchemistry |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aDrugs, Investigational |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 773 | 0 |
_tCurrent opinion in investigational drugs (London, England : 2000) _gvol. 2 _gno. 3 _gp. 372-4 |
|
| 999 |
_c11497394 _d11497394 |
||